Catherine Hackett

News

FDA approves Fitbit’s AFib-detection software

Author:: Catherine Hackett

Publish date: April 12, 2022

Fitbit has gained approval for an algorithm that will power an upcoming AFib-detection feature.

News

POISE-3 backs wider use of tranexamic acid in noncardiac surgery

Author:: Catherine Hackett

Publish date: April 2, 2022

The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role f...

News

FDA: More metformin extended-release tablets recalled

Author:: Catherine Hackett

Publish date: June 14, 2021

Two lots of 750-mg metformin HCl tablets were recalled by Viona after testing revealed nitrosodimethylamine (NDMA...

News

FDA approves metoclopramide nasal spray for diabetic gastroparesis

Author:: Catherine Hackett

Publish date: June 23, 2020

Via nasal administration, Gimoti bypasses the GI tract and enters the bloodstream directly for more “predictable ...

News

ACC is canceled. Now what?

Author:: Catherine Hackett

Publish date: March 9, 2020

Safety concerns and travel restrictions drove the college’s decision to cancel ACC.20/WCC, but parts of the meeti...

News

Icosapent ethyl approved for cardiovascular risk reduction

Author:: Catherine Hackett

Publish date: December 13, 2019

The Food and Drug Administration’s decision on reduction of events in high-risk patients was based primarily on the REDUCE-IT trial results.

News

Hyperkalemia-related treatment changes linked to death in acute HF

Author:: Catherine Hackett

Publish date: November 21, 2019

It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.

Video

‘Phenomenal’ REDUCE-IT establishes triglyceride theory

Author:: Catherine Hackett

Publish date: November 20, 2018

Why did REDUCE-IT succeed while other trials and compounds failed? Dr. Deedwania explains that it, for the first time, used the appropriate treatme...